Abstract
Radiofrequency catheter ablation has been established as a non-surgical curative treatment modality for the management of patients with paroxismal supraventricular tachycardia. Success rates for atrioventricular node reentrant tachycardia and accessory pathway-mediated macroreentrant tachycardia exceed 95%. Results in patients with atrial flutter and atrial tachycardia are encouraging, with success rates exceeding 75%.
MeSH terms
-
Atrial Fibrillation / physiopathology
-
Atrial Fibrillation / surgery
-
Atrial Flutter / physiopathology
-
Atrial Flutter / surgery
-
Catheter Ablation* / adverse effects
-
Electrocardiography
-
Heart Conduction System / physiopathology
-
Humans
-
Tachycardia, Paroxysmal / physiopathology
-
Tachycardia, Paroxysmal / surgery
-
Tachycardia, Supraventricular / physiopathology
-
Tachycardia, Supraventricular / surgery*
-
Wolff-Parkinson-White Syndrome / physiopathology
-
Wolff-Parkinson-White Syndrome / surgery